Literature DB >> 9452725

[Thymic and bronchial neuroendocrine tumors in multiple endocrine neoplasia type 1. GENEM1].

A Murat1, M F Heymann, S Bernat, B Dupas, A Y Delajartre, A Calender, P Despins, J L Michaud, S Giraud, M F Le Bodic, B Charbonnel.   

Abstract

OBJECTIVES: Multiple endocrine neoplasia type 1 (MEN 1) mainly affects parathyroid glands, pancreatic islets and pituitary gland. The aim of this study in 95 MEN 1 patients was to examine less frequent localizations thymic and bronchic neuroendocrine tumors (NET). PATIENTS AND METHODS: Two cases of bronchic NET were observed, both in women, and 4 cases of thymic NET, all in men, giving a prevalence of 7.3%. These NET were often asymptomatic. A metastatic diffusion was observed in 3 cases. Elevated plasma levels of glycoprotein hormone alpha subunit (SU) and FSH were observed in 3 and 1 cases respectively. Immunohistochemistry indicated the tumor cells to be frequently positively stained for HCG alpha and FSH. DISCUSSION: We conclude that all patients with MEN 1 should undergo screening for thoracic NET, especially in high risk familial subgroups and in case of elevated plasma alpha SU or FSH.

Entities:  

Mesh:

Year:  1997        PMID: 9452725

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

Authors:  Pierre Goudet; Arnaud Murat; Catherine Cardot-Bauters; Philippe Emy; Eric Baudin; Hélène du Boullay Choplin; Yves Chapuis; Jean-Louis Kraimps; Jean-Louis Sadoul; Antoine Tabarin; Bruno Vergès; Bruno Carnaille; Patricia Niccoli-Sire; Annie Costa; Alain Calender
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

2.  Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center.

Authors:  Ioannis Christakis; Wei Qiu; Angelica M Silva Figueroa; Samuel Hyde; Gilbert J Cote; Naifa L Busaidy; Michelle Williams; Elizabeth Grubbs; Jeffrey E Lee; Nancy D Perrier
Journal:  Horm Cancer       Date:  2016-06-16       Impact factor: 3.869

Review 3.  Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?

Authors:  Marco Volante; Ozgur Mete; Giuseppe Pelosi; Anja C Roden; Ernst Jan M Speel; Silvia Uccella
Journal:  Endocr Pathol       Date:  2021-02-27       Impact factor: 3.943

4.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.